Latest Press Releases

Viz.ai and Cercare Medical Partner to Support Neurovascular Clinical Decision Making

November 30, 2022

Viz.ai and Cercare Medical Partner to Support Neurovascular Clinical Decision Making

New partnership incorporates latest perfusion technology into the Viz.ai platform

Viz.ai Launches AI-powered Viz™ Radiology Suite

November 28, 2022

Viz.ai Launches AI-powered Viz™ Radiology Suite

Comprehensive solution tailored for radiologists to expedite patient diagnosis and treatment

November 28, 2022

Viz.ai Appoints Radiology Advisory Board to Advance Innovation

November 18, 2022

Viz Aortic Real-World Evidence

November 16, 2022

Viz.ai and Vastrax Join Forces to Accelerate Clinical Trial Enrollment

November 15, 2022

Viz.ai Partners with Illuminate to Improve Quality of Care for Aortic Aneurysm Patients

November 10, 2022

New Study Finds 85% of Aneurysms Identified by Viz™ ANEURYSM had not Been Referred for Neurovascular Review

November 4, 2022

Viz.ai Launches AI-Powered Viz™ Cardio Suite

November 2, 2022

Viz.ai Partners with Us2.ai to Deliver AI-Enabled Echocardiography Decision Support with the Viz™ Platform

October 25, 2022

Viz.ai Names Jieun Choe Chief Marketing Officer

September 1, 2022

Viz.ai Receives FDA 510(k) Clearance for Automated RV/LV Analysis Algorithm

Viz.ai Receives FDA 510(k) Clearance for Viz™ SUBDURAL (SDH)

Viz.ai Partners with Hyperfine to Enable New MR Imaging and Workflow Paradigm

Artificial Intelligence to Assist with Patient Enrollment for AngioDynamics’ AlphaVac System Study on Pulmonary Embolism Treatment

Viz.ai Raises $100 Million in Series D Funding, Led by Tiger Global and Insight Partners at $1.2 Billion Valuation

February 24, 2022

Viz.ai Receives FDA 510(k) Clearance for Viz™ ANEURYSM

February 11, 2022

New Data Presented at ISC 2022 Further Validates Impact of the Viz™ Platform for Intelligent Care Coordination in the Real World

February 9, 2022

Viz.ai and TeleSpecialists Announce Strategic Partnership

November 17, 2021

Viz.ai Debuts Viz™ ANX, the First AI-powered Cerebral Aneurysm Detection Solution at SVIN 2021

November 16, 2021

Viz.ai Launches Two New AI-Powered Modules for Pulmonary Embolism and Aortic Disease

Viz.ai Receives New Technology Add-on Payment Renewal for Stroke AI Software from CMS

Viz.ai and Avicenna.AI Partner

Viz.ai Receives CE Mark to Bring Life-saving Stroke Care to Europe

New Data on Stroke Care Show the Impact of Viz.ai’s Artificial Intelligence-Powered Platform on Patient Outcomes

Viz.ai Raises $71 Million Series C Round Led by Scale Venture Partners and Insight Partners

October 29, 2020

Record Number of Health Systems Choose Viz.ai's AI-Powered Synchronized Stroke Care Solution to Improve Patient Outcomes

October 1, 2020

Viz.ai Wins UCSF's 2020 Digital Health Award for Best New Application of A.I.

September 3, 2020

Viz.ai Granted Medicare New Technology Add-on Payment

November 15, 2018

Viz.ai and NICO Corp. Announce Collaboration to Speed Patient Recruitment in the ENRICH Study

November 14, 2018

Viz.ai Designated as American Heart Association/American Stroke Association Get With the Guidelines® Compatible Vendor

Late breaking: New study finds 85% of aneurysms identified by Viz™ ANEURYSM had not been referred for neurovascular review